Clinical Advances in
The programs on this page raise awareness of emergent therapies for NHL, the biological and clinical rationale for these treatments and the supporting evidence, and provide practical guidance on their optimal application in real-world practice.
Supported by an independent educational grant from
Steering Committee Chair
Professor of Medicine
Chief of the Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Associate Professor of Medicine
Harvard Medical School
Director, Center for Lymphoma
Massachusetts General Hospital
Boston, Massachusetts, United States
Chief, Department of Hematology
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
Department of Hematology location AMC
LYMMCARE (Lymphoma and Myeloma Center Amsterdam)
Amsterdam, Netherlands
Professor for Cellular Immunotherapy
Associate Professor for Hematology
University Hospital of Munich
Munich, Bavaria, Germany
Hematology Consultant Candiolo Cancer Institute,Fondazione Piemontese per l'Oncologia-IRCCS
Candiolo (Torino), Italy